Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your molecular cloning with our proprietary Gateway recombination technology. Transfer genes seamlessly between vectors without restriction enzymes or ligases, achieving >95% cloning efficiency in just one hour.
Trusted by leading research and pharmaceutical institutions
attB × attP → attL Entry Clone
attL × attR → Expression Clone
Up to 4 fragments in one reaction
Our proprietary Gateway cloning platform enables seamless gene transfer between vectors with unmatched efficiency and reliability.
Our proprietary enzyme mixes catalyze site-specific recombination between att sites in just one hour at room temperature. No restriction enzymes, no ligase, no gel purification required.
Transfer your gene of interest from entry clones to hundreds of Gateway destination vectors for expression in bacterial, yeast, insect, and mammalian systems.
Both BP and LR reactions can be reversed for fragment recovery or reuse.
Clone 2-4 DNA fragments simultaneously into a single vector in one reaction.
Every clone is Sanger sequenced to guarantee 100% accuracy.
Get expert support for your Gateway cloning project.
Based on λ integrase site-specific recombination for highly efficient and directional cloning.
Catalyzes attB × attP recombination to generate attL-flanked entry clones. Highly efficient and reliable.
Transfers genes from entry clones to destination vectors. Generates >5000 colonies per reaction.
Assemble 2-4 DNA fragments simultaneously in a single reaction with precise orientation.
Comprehensive specifications to meet your research requirements.
| Parameter | Entry Clone Construction | Expression Clone | MultiSite Assembly |
|---|---|---|---|
| Insert Size | 100 bp - 11 kb | Up to 15 kb | 2-4 fragments |
| Reaction Time | 1 hour (25°C) | 1 hour (25°C) | 16-18 hours |
| Cloning Efficiency | >95% | >95% | 70-90% |
| Verification | Sanger sequencing | Sanger + restriction | Colony PCR + seq |
| Selection | Kanamycin + ccdB | Ampicillin + ccdB | Multiple markers |
| Delivery Format | Plasmid DNA + glycerol | Plasmid DNA + COA | Validated clones |
Our streamlined workflow ensures efficiency and reliability at every stage.
Submit sequences and vector specs
Entry clone construction
Expression clone generation
Sanger sequencing verification
Plasmid + COA report
Our Gateway cloning services support research and development in multiple fields.
Rapidly transfer your gene of interest into multiple destination vectors to find the optimal expression system. Test different tags, promoters, and host cells in parallel.
Clone entire cDNA libraries into entry clone collections for high-throughput functional analysis. Transfer clones to diverse assay vectors for systematic studies.
Combine 2-4 DNA fragments (promoter, ORF, tag) simultaneously into a single vector in one reaction. Maintain precise orientation and reading frame.
Trusted by researchers worldwide for quality and reliability.
"The cloning efficiency is remarkable. We've switched from traditional restriction cloning to Gateway and our project timelines have shortened significantly. The technical support is excellent."
"Gateway cloning has been essential for our high-throughput protein expression screen. The ability to transfer ORFs to multiple vectors in parallel has accelerated our discovery pipeline."
"We use MultiSite Gateway for assembling complex multi-component constructs. The efficiency and directionality are excellent. Sequencing verification gives us confidence in every clone."
Our platform is backed by peer-reviewed research.
Nivina A, Grieb MS, Loot C, et al. Science Advances. 2020.
Development of structure-specific recombination technology based on integrase systems with minimal sequence constraints.
Vo PLH, Ronda C, Klompe SE, et al. Nature Biotechnology. 2020.
INTEGRATE system achieving ~100% efficiency for precise, marker-free DNA integration up to 10 kb.
Yang D, Liu C, et al. Biochimie. 2020.
Rapid One-Step Gateway cloning method eliminating BP reaction step, saving time and cost.
Reece-Hoyes JS, Walhout AJM. Cold Spring Harbor Protocols. 2018.
Comprehensive protocol guide for Gateway cloning system based on λ integrase recombination.
Multiple authors. Nucleic Acids Research. 2020.
Lambda integrase-based platform for efficient large transgene (>10kb) insertion in human cells.
Find answers to common questions about our Gateway cloning service.
Get a customized quote for your Gateway Cloning Service project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.